Value Market Research provides a forecast for the Global Leukemia Therapeutics Market between 2018 and 2024. The market was valued USD 10 BN (by revenue) in 2017 and is anticipated to reach USD 13 BN by 2024 with a CAGR of 4%. The study offers a detailed analysis of the various factors driving the market growth path, trends and challenges. The report has also emphasized the competitive landscape along with the latest technological development undertaken during the forecast period.
The market of leukemia therapeutic is likely to create numerous opportunity in the years to come owing to the promising pipeline and positive clinical outcome of the treatment. Respective regulatory bodies are also supporting the leukemia therapeutic market by providing funding and grants. Rising demand for safe and effective medications, the advent of technological advancements along with the increasing cases of cancers are topmost factors fueling the industry proliferation. On the other hand, expenses associated with the research and development along with the side effects related to the treatment is the only major factor that can act as a challenge for the market.
The report - "Global Leukemia Therapeutics Market Report By Therapy (Chemotherapy, Biological Therapy, Radiation Therapy, Targeted Therapy, And Other), Type (Chronic Leukemia, Chronic Lymphatic Leukemia, Chronic Myeloid Leukemia, Acute Leukemia, Acute Lymphatic Leukemia, Acute Myeloid Leukemia, And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2017-2024 "- offer first-string market insights to give a thorough understanding of industry dynamics and facilitate intelligent decision making.
Nowadays almost half of the cancers are caused by unhealthy lifestyle led by people. Leukemia is one of the most common types of cancer that occur in the blood-forming tissues and restrict the ability of the body to fight against infection. It is mostly caused by exposure to radiations, various environmental factors, and bad eating habits.
Segmentation has been done on the basis of therapy, type, and region. Therapy include chemotherapy, biological therapy, radiation therapy, targeted therapy, and other. Out of this chemotherapy is gaining hype since it is a most common type of treatment and has the highest survival rate of the patients. Type of leukemia is chronic leukemia, chronic lymphatic leukemia, chronic myeloid leukemia, acute leukemia, acute lymphatic leukemia, acute myeloid leukemia, and others. Acute leukemia is dominating the segment as it has been accounted for the highest rate of occurrence among people owing to unhealthy lifestyle and exposure to harsh environment and radiation. Regionally, the study has been conducted across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. From the geographical perspective, North America has been accounted for the highest share in the market owing to the rising geriatric population base, increasing the number of cancer cases among people along with the rising funding by the government on R&D in order to develop an effective treatment in the region.
The Report Segments Global Leukemia Therapeutics Market -
Players Involved In The Market:
AbbVie Inc., Amgen, ARIAD Pharmaceuticals, Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Genzyme Corporation, GlaxoSmithKline plc., Novartis International AG., Pfizer, and Teva Pharmaceuticals.
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.
We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Email: [email protected]